Anaemia in older persons

Netherlands Journal of Medicine

Volumn 69, Issue 6, 2011, Pages 260-267

  den Elzen, W P J ^a   Gussekloo, J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aged; Anaemia; Erythropoietin; Ferritin; Folate; Mortality; Myelodysplasia; Telomere length; Vitamin B 12

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEPCIDIN;

AGED; ALGORITHM; ANEMIA; CYANOCOBALAMIN DEFICIENCY; FOLLOW UP; GERIATRIC PATIENT; HUMAN; INFLAMMATION; IRON DEFICIENCY; KIDNEY FUNCTION; MORTALITY; PERNICIOUS ANEMIA; PRACTICE GUIDELINE; REVIEW; TELOMERE; VITAMIN SUPPLEMENTATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; COMORBIDITY; HUMANS; SEX FACTORS; VITAMIN B 12 DEFICIENCY;

EID: 80051757161     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Beghe C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med. 2004;116 Suppl 7A 3S-10S.
2. Gaskell H, Derry S, Andrew MR, McQuay HJ. Prevalence of anaemia in older persons: systematic review. BMC Geriatr. 2008;8:1.
3. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood.2004;104(8):2263-8.
4. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5-37.
5. den Elzen WP, Willems JM, Westendorp RG, de Craen AJ, Assendelft WJ, Gussekloo J. Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study. CMAJ.2009;181(3-4):151-7.
6. Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA. 1999;281(18):1714-7.
7. Chaves PH, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc. 2004;52(11):1811-6.
8. Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med. 2006;119(4):327-34.
9. Zakai NA, Katz R, Hirsch C, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med. 2005;165(19):2214-20.
10. Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR. Impact of anemia on hospitalization and mortality in older adults. Blood. 2006;107(10):3841-6.
11. Chaves PH. Functional outcomes of anemia in older adults. Semin Hematol. 2008;45(4):255-60.
12. Beard CM, Kokmen E, O'Brien PC, Ania BJ, Melton LJ, III. Risk of Alzheimer's disease among elderly patients with anemia: populationbased investigations in Olmsted County, Minnesota. Ann Epidemiol.1997;7(3):219-24.
13. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc. 2002;50(7):1257-64.
14. Lipschitz D. Medical and functional consequences of anemia in the elderly. J Am Geriatr Soc. 2003;51(3 Suppl):S10-S13.
15. Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15 Suppl 314-8.
16. Onder G, Penninx BW, Cesari M, et al. Anemia is associated with depression in older adults: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2005;60(9):1168-72.
17. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M. Anemia and decline in physical performance among older persons. Am J Med. 2003;115(2):104-10.
18. Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52(5):719-24.
19. Penninx BW, Pluijm SM, Lips P, et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc. 2005;53(12):2106-11.
20. Salive ME, Cornoni-Huntley J, Guralnik JM, et al. Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc. 1992;40(5):489-96.
21. Eisenstaedt R, Penninx BW, Woodman RC. Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 2006;20(4):213-26.
22. Robinson B. Cost of anemia in the elderly. J Am Geriatr Soc. 2003;51(3 Suppl):S14-S17.
23. Kolnaar BGM, Van Wijk MAM, Pijnenborg L, Assendelft WJJ. Summary of the Dutch College of General Practitioners' practice guideline 'anaemia'. Ned Tijdschr Geneeskd. 2003;147(40):1956-61.
24. Smith DL. Anemia in the elderly. Am Fam Physician. 2000;62(7):1565-72.
25. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75(5):671-8.
26. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591-9.
27. van Bemmel T, Gussekloo J, Westendorp RG, Blauw GJ. In a populationbased prospective study, no association between high blood pressure and mortality after age 85 years. J Hypertens. 2006;24(2):287-92.
28. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RG. Total cholesterol and risk of mortality in the oldest old. Lancet. 1997;350(9085):1119-23.
29. Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, Gussekloo J, Westendorp RG. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med. 2003;163(13):1549-54.
30. Biermer A. Uber eine Form von progressiver peniciöser Anämie. Schweiz Arzte. 1872;215-7.
31. Minot GR, Murphy WP. Treatment of pernicious anemia by a special diet. JAMA. 1926;87 470-6.
32. Lester-Smith E. Purification of the anti-pernicious anaemia factor from liver extracts. Nature. 1948;161 638-9.
33. Rickes EL, Brink NG, Koniusky FR, Wood TR, Folkers K. Crystalline vitamin B12. Science. 1948;107 396-7.
34. Okuda K. Discovery of vitamin B12 in the liver and its absorption factor in the stomach: a historical review. J Gastroenterol Hepatol. 1999;14(4):301-8.
35. Chanarin I. Historical review: a history of pernicious anaemia. Br J Haematol. 2000;111(2):407-15.
36. Whittingham S, Mackay IR. Autoimmune gastritis: historical antecedents, outstanding discoveries, and unresolved problems. Int Rev Immunol.2005;24(1-2):1-29.
37. Mooney FS, Heathcote JG. Oral treatment of pernicious anaemia: first fifty cases. Br Med J. 1966;1(5496):1149-51.
38. Andres E, Kaltenbach G, Noel E et al. Efficacy of short-term oral cobalamin therapy for the treatment of cobalamin deficiencies related to food-cobalamin malabsorption: a study of 30 patients. Clin Lab Haematol. 2003;25(3):161-6.
39. Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther.2003;25(12):3124-34.
40. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood.1998;92(4):1191-8.
41. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990;76(5):871-81.
42. Andres E, Loukili NH, Noel E et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251-9.
43. Wolters M, Strohle A, Hahn A. Cobalamin: a critical vitamin in the elderly. Prev Med. 2004;39(6):1256-66.
44. Babior BM, Bunn HF. Megaloblastic Anemias. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL et al, editors. Harrison's Principles of Internal Medicine, 16 ed. New York, McGraw-Hill. 2004.602-7.
45. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 1992;40(12):1197-204.
46. Clarke R, Refsum H, Birks J, et al. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr. 2003;77(5):1241-7.
47. Stabler SP. Screening the older population for cobalamin (vitamin B12) deficiency. J Am Geriatr Soc. 1995;43(11):1290-7.
48. Martens JH, Barg H, Warren MJ, Jahn D. Microbial production of vitamin B12. Appl Microbiol Biotechnol. 2002;58(3):275-85.
49. Samson D, Halliday D, Chanarin I. Reversal of ineffective erythropoiesis in pernicious anaemia following vitamin B12 therapy. Br J Haematol.1977;35(2):217-24.
50. Myhre E. Studies on megaloblasts in vitro. I. Proliferation and destruction of nucleated red cells in pernicious anemia before and during treatment with vitamin B12. Scand J Clin Lab Invest. 1964;16 307-19.
51. den Elzen WP, Westendorp RG, Frolich M, de Ruijter W, Assendelft WJ, Gussekloo J. Vitamin B12 and folate and the risk of anemia in old age: the Leiden 85-Plus Study. Arch Intern Med. 2008;168(20):2238-44.
52. den Elzen WP, van der Weele GM, Gussekloo J, Westendorp RG, Assendelft WJ. Subnormal vitamin B12 concentrations and anaemia in older people: a systematic review. BMC Geriatr. 2010;10:42.
53. Hughes D, Elwood PC, Shinton NK, Wrighton RJ. Clinical trial of the effect of vitamin B12 in elderly subjects with low serum B12 levels. Br Med J.1970;1(5707):458-60.
54. Hvas AM, Ellegaard J, Nexo E. Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebocontrolled study. Clin Chem. 2001;47(8):1396-404.
55. Seal EC, Metz J, Flicker L, Melny J. A randomized, double-blind, placebocontrolled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc. 2002;50(1):146-51.
56. Mooijaart SP, Gussekloo J, Frolich M, et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study. Am J Clin Nutr. 2005;82(4):866-71.
57. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet. 2004;17(4):371-83.
58. Malouf R, Areosa SA. Vitamin B12 for cognition. Cochrane Database Syst Rev. 2003;(3):CD004326.
59. den Elzen WP, Westendorp RG, Frolich M, de Ruijter W, Assendelft WJ, Gussekloo J. Role of Vitamin B12 in Anemia in Old Age - In reply. Arch Intern Med. 2009;169(12):168.
60. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist. 1996;618 781-97.
61. Tucker KL, Mahnken B, Wilson PW, Jacques P, Selhub J. Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. JAMA. 1996;276(23):1879-85.
62. Gezondheidsraad. Naar een optimaal gebruik van foliumzuur, publicatienr 2008/02 ed. Den Haag, 2008.
63. Guyatt GH, Patterson C, Ali M, et al. Diagnosis of iron-deficiency anemia in the elderly. Am J Med. 1990;88(3):205-9.
64. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol. 1973;26(10):770-2.
65. Nelson R, Chawla M, Connolly P, LaPorte J. Ferritin as an index of bone marrow iron stores. South Med J. 1978;71(12):1482-4.
66. Clark SF. Iron deficiency anemia. Nutr Clin Pract. 2008;23(2):128-41.
67. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992;7(2):145-53.
68. Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;290(22):1213-6.
69. Worwood M. Serum ferritin. CRC Crit Rev Clin Lab Sci. 1979;10(2):171-204.
70. den Elzen WP, Gussekloo J, Willems JM, et al. Predictive value of low ferritin in older persons with anemia with and without inflammation: the Leiden 85-plus Study. J Am Geriatr Soc. 2010;58(8):1601-3.
71. Zarychanski R, Houston DS. Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ. 2008;179(4):333-7.
72. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271-6.
73. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-3.
74. Ganz T. Iron homeostasis: fitting the puzzle pieces together. Cell Metab. 2008;7(4):288-90.
75. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783-8.
76. Nemeth E. Iron regulation and erythropoiesis. Curr Opin Hematol.2008;15(3):169-75.
77. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A.2002;99(7):4596-601.
78. Roy CN, Mak HH, Akpan I, Losyev G, Zurakowski D, Andrews NC. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood. 2007;109(9):4038-44.
79. Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood. 2005;105(4):1797-802.
80. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106(6):2196-9.
81. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica.2006;91(6):727-32.
82. Roy CN, Andrews NC. Anemia of inflammation: the hepcidin link. Curr Opin Hematol. 2005;12(2):107-11.
83. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26 323-42.
84. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med.2005;352(10):1011-23.
85. Ferrucci L, Semba RD, Guralnik JM, et al. Proinflammatory state, hepcidin and anemia in older persons. Blood. 2010;115(18):3810-6.
86. Swinkels DW, Girelli D, Laarakkers C, et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS ONE.2008;3(7):e2706.
87. Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica. 2008;93(1):90-7.
88. Ganz T, Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med. 2011;62 347-60.
89. Adamson JW, Longo DL. Chapter 58. Anemia and Polycythemia: Introduction. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL et al, editors. Harrison's Principles of Internal Medicine, 17 ed. 2008.
90. Krantz SB. Erythropoietin. Blood. 1991;77(3):419-34.
91. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev. 1992;72(2):449-89.
92. Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood.1999;94(6):1864-77.
93. Volpe M, Tritto C, Testa U, et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol. 1994;74(5):468-73.
94. Ble A, Fink JC, Woodman RC, et al. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med.2005;165(19):2222-7.
95. Cody J, Daly C, Campbell M, et al. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev. 2005;(3):CD003266.
96. Evans RW, Rader B, Manninen DL. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA. 1990;263(6):825-30.
97. Bohlius J, Wilson J, Seidenfeld J, et al. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst. 2006;98(10):708-14.
98. Jones M, Schenkel B, Just J, Fallowfield L. Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis. Cancer. 2004;101(8):1720-32.
99. Agnihotri P, Telfer M, Butt Z, et al. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc.2007;55(10):1557-65.
100. van der Meer P, Voors AA, Lipsic E, Smilde TD, van Gilst WH, van Veldhuisen DJ. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol. 2004;44(1):63-7.
101. George J, Patal S, Wexler D, et al. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers. Arch Intern Med.2005;165(11):1304-9.
102. Avkarogullari M, Bozkurt A, Akpinar O, Donmez Y, Demirtas M. The relation between serum erythropoietin level and severity of disease and mortality in patients with chronic heart failure. Acta Cardiol.2008;63(3):297-302.
103. van der Meer P, Lok DJ, Januzzi JL, et al. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. Eur Heart J. 2008;29(12):1510-15.
104. Belonje AM, Westenbrink BD, Voors AA et al. Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan. Am Heart J. 2009;157(1):91-6.
105. Belonje AM, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, van Veldhuisen DJ. Endogenous erythropoietin and outcome in heart failure. Circulation. 2010;121(2):245-51.
106. den Elzen WP, Willems JM, Westendorp RG, et al. Effect of erythropoietin levels on mortality in old age: the Leiden 85-plus Study. CMAJ.2010;182(18):1953-8.
107. Ershler WB, Sheng S, McKelvey J, et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc. 2005;53(8):1360-5.
108. Price EA. Aging and erythropoiesis: current state of knowledge. Blood Cells Mol Dis. 2008;41(2):158-65.
109. Brines M, Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med.2008;264(5):405-32.
110. Bohlius J, Schmidlin K, Brillant C et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet. 2009;373(9674):1532-42.
111. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet.2007;369(9559):381-8.
112. Tonelli M, Hemmelgarn B, Reiman T, et al. Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis. CMAJ. 2009;180(11):E62-E71.
113. Lipschitz DA, Mitchell CO, Thompson C. The anemia of senescence. Am J Hematol. 1981;11(1):47-54.
114. Lipschitz DA, Udupa KB, Milton KY, Thompson CO. Effect of age on hematopoiesis in man. Blood. 1984;63(3):502-9.
115. Rothstein G. Disordered hematopoiesis and myelodysplasia in the elderly. J Am Geriatr Soc. 2003;51(3 Suppl):S22-S26.
116. Pfeilstocker M, Karlic H, Nosslinger T, et al. Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications. Leuk Lymphoma. 2007;48(10):1900-9.
117. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci.2002;27(7):339-44.
118. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science.1998;279(5349):349-52.
119. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003;426(6963):194-8.
120. Martin-Ruiz C, Dickinson HO, Keys B, et al. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol.2006;60(2):174-80.
121. Panossian LA, Porter VR, Valenzuela HF, et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging.2003;24(1):77-84.
122. von Zglinicki T, Serra V, Lorenz M, et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest. 2000;80(11):1739-47.
123. Yaffe K, Lindquist K, Kluse M, et al. Telomere length and cognitive function in community-dwelling elders: Findings from the Health ABC Study. Neurobiol Aging. 2009;doi:10.1016/j. neurobiolagingn.2009.12.006.
124. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol. 2003;23(5):842-6.
125. Collerton J, Martin-Ruiz C, Kenny A, et al. Telomere length is associated with left ventricular function in the oldest old: the Newcastle 85+ study. Eur Heart J. 2007;28(2):172-6.
126. Benetos A, Gardner JP, Zureik M, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension. 2004;43(2):182-5.
127. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003;95(16):1211-8.
128. H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stemnnn cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A.1994;91(21):9857-60.
129. Globerson A. Hematopoietic stem cells and aging. Exp Gerontol. 1999;34(2):137-46.
130. Lansdorp PM. Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci. 1995;108 (Pt 1)1-6.
131. Boultwood J, Fidler C, Kusec R et al. Telomere length in myelodysplastic syndromes. Am J Hematol. 1997;56(4):266-71.
132. Lange K, Holm L, Vang NK, et al. Telomere shortening and chromosomal instability in myelodysplastic syndromes. Genes Chromosomes Cancer.2010;49(3):260-9.
133. Sashida G, Ohyashiki JH, Nakajima A, et al. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases. Clin Cancer Res. 2003;9(4):1489-96.
134. Wong LS, Huzen J, van der Harst, et al. Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure. Eur J Heart Fail. 2010;12(4):348-53.
135. De Meyer T, De Buyzere ML, Langlois M, et al. Lower red blood cell counts in middle-aged subjects with shorter peripheral blood leukocyte telomere length. Aging Cell. 2008;7(5):700-5.
136. den Elzen WP, Martin-Ruiz CM, von Zglinicki T, Westendorp RG, kirkwood TB, Gussekloo J. Telomere length and anaemia in old age. Results from the Newcastle 85-plus Study and the Leiden 85-plus Study. Age Ageing. [in press].
137. Mollica L, Fleury I, Belisle C, Provost S, Roy DC, Busque L. No association between telomere length and blood cell counts in elderly individuals. J Gerontol A Biol Sci Med Sci. 2009;64(9):965-7.